Osteogenic response to BMP-2 of hMSCs grown on apatite-coated scaffolds

Biotechnology and Bioengineering

Volumn 108, Issue 11, 2011, Pages 2727-2735

  Davis, Hillary E ^a   Case, Erin M ^a   Miller, Stephanie L ^a   Genetos, Damian C ^a   Leach, J Kent ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone morphogenetic protein; Osteoconductivity; Osteoinductive; Scaffold; Simulated body fluid

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE REPAIR; BONE TISSUE; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IN-VIVO; MULTIPLE PATHWAYS; OSTEOCONDUCTIVE; OSTEOCONDUCTIVE MATERIALS; OSTEOCONDUCTIVITY; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC RESPONSE; OSTEOINDUCTIVE; POLYMER SCAFFOLDS; PROGENITOR CELL; SIMULATED BODY FLUIDS; TIME POINTS;

APATITE; BONE; BONE CEMENT; CELL CULTURE; COATED MATERIALS; GENE EXPRESSION; PHOSPHATASES; SCAFFOLDS; STEM CELLS; SUBSTRATES; TISSUE;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; APATITE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; OSTEONECTIN; POLYMER; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR RUNX2;

ADSORPTION; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYDROPHILICITY; MESENCHYMAL STEM CELL;

ALKALINE PHOSPHATASE; APATITES; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION PROFILING; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; MESENCHYMAL STEM CELLS; OSTEOGENESIS; OSTEONECTIN; TRANSCRIPTION FACTORS;

EID: 80053051910     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.23227     Document Type: Article

References (39)

1. Autefage H, Briand-Mésange F, Cazalbou S, Drouet C, Fourmy D, Gonçalvès S, Salles J-P, Combes C, Swider P, Rey C. 2009. Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/β-tricalcium phosphate porous ceramics. J Biomed Mater Res Part B: Appl Biomater 91B(2): 706-715.
2. Bauer TW. 2007. An overview of the histology of skeletal substitute materials. Arch Pathol Lab Med 131(2): 217-224.
3. Bauer TW, Muschler GF. 2000. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res (371): 10-27.
4. Bauer TW, Schils J. 1999. The pathology of total joint arthroplasty. Skeletal Radiol 28(9): 483-497.
5. Bhumiratana S, Grayson WL, Castaneda A, Rockwood DN, Gil ES, Kaplan DL, Vunjak-Novakovic G. 2011. Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds. Biomaterials 32(11): 2812-2820.
6. Celil AB, Hollinger JO, Campbell PG. 2005. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 95(3): 518-528.
7. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. 1991. Controlled delivery systems for proteins based on poly(lactic glycolic acid) microspheres. Pharmaceut Res 8(6): 713-720.
8. Cohen SA, Sideman L. 1979. Modification of the o-cresolphthalein complexone method for determining calcium. Clin Chem 25(8): 1519-1520.
9. Davis HE, Rao RR, He J, Leach JK. 2009. Biomimetic scaffolds fabricated from apatite-coated polymer microspheres. J Biomed Mater Res Part A 90A(4): 1021-1031.
10. Dong X, Wang Q, Wu T, Pan H. 2007. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 93(3): 750-759.
11. Einhorn TA. 1998. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355: S7-S21.
12. Engler AJ, Sen S, Sweeney HL, Discher DE. 2006. Matrix elasticity directs stem cell lineage specification. Cell 126(4): 677-689.
13. Habraken W, Wolke JGC, Jansen JA. 2007. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59(4-5): 234-248.
14. He J, Genetos DC, Leach JK. 2010. Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds. Tissue Eng Part A 16(1): 127-137.
15. Jongpaiboonkit L, Franklin-Ford T, Murphy WL. 2009. Mineral-coated polymer microspheres for controlled protein binding and release. Adv Mater 21(19): 1960-1963.
16. Jørgensen NR, Henriksen Z, Sørensen OH, Civitelli R. 2004. Dexamethasone, BMP-2, and 1, 25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: Validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69(4): 219-226.
17. Kang S-W, Yang HS, Seo S-W, Han DK, Kim B-S. 2008. Apatite-coated poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for bone tissue engineering. J Biomed Mater Res Part A 85A(3): 747-756.
18. Kay S, Thapa A, Haberstroh KM, Webster TJ. 2002. Nanostructured polymer/nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng 8(5): 753-761.
19. Kim HJ, Kim U-J, Kim HS, Li C, Wada M, Leisk GG, Kaplan DL. 2008. Bone tissue engineering with premineralized silk scaffolds. Bone 42(6): 1226-1234.
20. Kim SS, Ahn KM, Park MS, Lee JH, Choi CY, Kim BS. 2007. A poly(lactide-co-glycolide)/hydroxyapatite composite scaffold with enhanced osteoconductivity. J Biomed Mater Res Part A 80A(1): 206-215.
21. Kim SS, Park MS, Jeon O, Choi CY, Kim BS. 2006. Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 27(8): 1399-1409.
22. Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, Gazit D. 2007. Gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 13(6): 1135-1150.
23. Komatsu DE, Warden SJ. 2010. The control of fracture healing and its therapeutic targeting: Improving upon nature. J Cell Biochem 109(2): 302-311.
24. Kretlow JD, Mikos AG. 2007. Mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng 13(5): 927-938.
25. Liu Y, Huse RO, de Groot K, Buser D, Hunziker EB. 2007. Delivery mode and efficacy of BMP-2 in association with implants. J Dent Res 86(1): 84-89.
26. Murphy WL, Hsiong S, Richardson TP, Simmons CA, Mooney DJ. 2005. Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials 26(3): 303-310.
27. Murphy WL, Mooney DJ. 2002. Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata. J Am Chem Soc 124(9): 1910-1917.
28. Murphy WL, Simmons CA, Kaigler D, Mooney DJ. 2004. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83(3): 204-210.
29. Mygind T, Stiehler M, Baatrup A, Li H, Zou X, Flyvbjerg A, Kassem M, Bünger C. 2007. Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials 28(6): 1036-1047.
30. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108(1): 17-29.
31. O'Heireamhoin S, Quinlan JF, Rourke KO. 2011. The use of bone morphogenetic protein 7 in fracture non-unions. Orthop Surg 3(1): 40-44.
32. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. 2004. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 176(1-3): 109-119.
33. Porter JR, Ruckh TT, Popat KC. 2009. Bone tissue engineering: A review in bone biomimetics and drug delivery strategies. Biotechnol Prog 25(6): 1539-1560.
34. Smith LL, Niziolek PJ, Haberstroh KM, Nauman EA, Webster TJ. 2007. Decreased fibroblast and increased osteoblast adhesion on nanostructured NaOH-etched PLGA scaffolds. Int J Nanomed 2(3): 383-388.
35. Tsuruga E, Takita H, Itoh H, Wakisaka Y, Kuboki Y. 1997. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 121(2): 317-324.
36. Whang K, Goldstick TK, Healy KE. 2000. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials 21(24): 2545-2551.
37. Whang K, Healy KE, Elenz DR, Nam EK, Tsai DC, Thomas CH, Nuber GW, Glorieux FH, Travers R, Sprague SM. 1999. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 5(1): 35-51.
38. Zhang P, Hong Z, Yu T, Chen X, Jing X. 2009. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(l-lactide). Biomaterials 30(1): 58-70.
39. Zhang R, Ma PX. 1999. Poly(α-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 44(4): 446-455.